Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Anika Großhennig is active.

Publication


Featured researches published by Anika Großhennig.


Nature Genetics | 2009

New susceptibility locus for coronary artery disease on chromosome 3q22.3

Jeanette Erdmann; Anika Großhennig; Peter S. Braund; Inke R. König; Christian Hengstenberg; Alistair S. Hall; Patrick Linsel-Nitschke; Sekar Kathiresan; Ben Wright; David-Alexandre Trégouët; François Cambien; Petra Bruse; Zouhair Aherrahrou; Arnika K. Wagner; Klaus Stark; Stephen M. Schwartz; Veikko Salomaa; Roberto Elosua; Olle Melander; Benjamin F. Voight; Christopher J. O'Donnell; Leena Peltonen; David S. Siscovick; David Altshuler; Piera Angelica Merlini; Flora Peyvandi; Luisa Bernardinelli; Diego Ardissino; Arne Schillert; Stefan Blankenberg

We present a three-stage analysis of genome-wide SNP data in 1,222 German individuals with myocardial infarction and 1,298 controls, in silico replication in three additional genome-wide datasets of coronary artery disease (CAD) and subsequent replication in ∼25,000 subjects. We identified one new CAD risk locus on 3q22.3 in MRAS (P = 7.44 × 10−13; OR = 1.15, 95% CI = 1.11–1.19), and suggestive association with a locus on 12q24.31 near HNF1A-C12orf43 (P = 4.81 × 10−7; OR = 1.08, 95% CI = 1.05–1.11).


JAMA | 2009

Genetic variants associated with cardiac structure and function: A meta-analysis and replication of genome-wide association data

Nicole L. Glazer; Janine F. Felix; Wolfgang Lieb; Philipp S. Wild; Stephan B. Felix; Norbert Watzinger; Martin G. Larson; Nicholas L. Smith; Abbas Dehghan; Anika Großhennig; Arne Schillert; Alexander Teumer; Reinhold Schmidt; Sekar Kathiresan; Thomas Lumley; Yurii S. Aulchenko; Inke R. König; Tanja Zeller; Georg Homuth; Maksim Struchalin; Jayashri Aragam; Joshua C. Bis; Fernando Rivadeneira; Jeanette Erdmann; Renate B. Schnabel; Marcus Dörr; Robert Zweiker; Lars Lind; Richard J. Rodeheffer; Karin Halina Greiser

CONTEXT Echocardiographic measures of left ventricular (LV) structure and function are heritable phenotypes of cardiovascular disease. OBJECTIVE To identify common genetic variants associated with cardiac structure and function by conducting a meta-analysis of genome-wide association data in 5 population-based cohort studies (stage 1) with replication (stage 2) in 2 other community-based samples. DESIGN, SETTING, AND PARTICIPANTS Within each of 5 community-based cohorts comprising the EchoGen consortium (stage 1; n = 12 612 individuals of European ancestry; 55% women, aged 26-95 years; examinations between 1978-2008), we estimated the association between approximately 2.5 million single-nucleotide polymorphisms (SNPs; imputed to the HapMap CEU panel) and echocardiographic traits. In stage 2, SNPs significantly associated with traits in stage 1 were tested for association in 2 other cohorts (n = 4094 people of European ancestry). Using a prespecified P value threshold of 5 x 10(-7) to indicate genome-wide significance, we performed an inverse variance-weighted fixed-effects meta-analysis of genome-wide association data from each cohort. MAIN OUTCOME MEASURES Echocardiographic traits: LV mass, internal dimensions, wall thickness, systolic dysfunction, aortic root, and left atrial size. RESULTS In stage 1, 16 genetic loci were associated with 5 echocardiographic traits: 1 each with LV internal dimensions and systolic dysfunction, 3 each with LV mass and wall thickness, and 8 with aortic root size. In stage 2, 5 loci replicated (6q22 locus associated with LV diastolic dimensions, explaining <1% of trait variance; 5q23, 12p12, 12q14, and 17p13 associated with aortic root size, explaining 1%-3% of trait variance). CONCLUSIONS We identified 5 genetic loci harboring common variants that were associated with variation in LV diastolic dimensions and aortic root size, but such findings explained a very small proportion of variance. Further studies are required to replicate these findings, identify the causal variants at or near these loci, characterize their functional significance, and determine whether they are related to overt cardiovascular disease.


Human Genetics | 2012

Personalized medicine using DNA biomarkers: a review

Andreas Ziegler; Armin Koch; Katja Krockenberger; Anika Großhennig

Biomarkers are of increasing importance for personalized medicine, with applications including diagnosis, prognosis, and selection of targeted therapies. Their use is extremely diverse, ranging from pharmacodynamics to treatment monitoring. Following a concise review of terminology, we provide examples and current applications of three broad categories of biomarkers—DNA biomarkers, DNA tumor biomarkers, and other general biomarkers. We outline clinical trial phases for identifying and validating diagnostic and prognostic biomarkers. Predictive biomarkers, more generally termed companion diagnostic tests predict treatment response in terms of efficacy and/or safety. We consider suitability of clinical trial designs for predictive biomarkers, including a detailed discussion of validation study designs, with emphasis on interpretation of study results. We specifically discuss the interpretability of treatment effects if a large set of DNA biomarker profiles is available and the number of therapies is identical to the number of different profiles.


Circulation-cardiovascular Genetics | 2010

Genetic Regulation of Serum Phytosterol Levels and Risk of Coronary Artery Disease

Daniel Teupser; Ronny Baber; Uta Ceglarek; Markus Scholz; Thomas Illig; Christian Gieger; Lesca M. Holdt; Alexander Benedikt Leichtle; Karin Halina Greiser; Dominik Huster; Patrick Linsel-Nitschke; Arne Schäfer; Peter S. Braund; Laurence Tiret; Klaus Stark; Dorette Raaz-Schrauder; Georg Martin Fiedler; Wolfgang Wilfert; Frank Beutner; Stephan Gielen; Anika Großhennig; Inke R. König; Peter Lichtner; Iris M. Heid; Alexander Kluttig; Nour Eddine El Mokhtari; Diana Rubin; Arif B. Ekici; André Reis; Christoph D. Garlichs

Background—Phytosterols are plant-derived sterols that are taken up from food and can serve as biomarkers of cholesterol uptake. Serum levels are under tight genetic control. We used a genomic approach to study the molecular regulation of serum phytosterol levels and potential links to coronary artery disease (CAD). Methods and Results—A genome-wide association study for serum phytosterols (campesterol, sitosterol, brassicasterol) was conducted in a population-based sample from KORA (Cooperative Research in the Region of Augsburg) (n=1495) with subsequent replication in 2 additional samples (n=1157 and n=1760). Replicated single-nucleotide polymorphisms (SNPs) were tested for association with premature CAD in a metaanalysis of 11 different samples comprising 13 764 CAD cases and 13 630 healthy controls. Genetic variants in the ATP-binding hemitransporter ABCG8 and at the blood group ABO locus were significantly associated with serum phytosterols. Effects in ABCG8 were independently related to SNPs rs4245791 and rs41360247 (combined P=1.6×10−50 and 6.2×10−25, respectively; n=4412). Serum campesterol was elevated 12% for each rs4245791 T-allele. The same allele was associated with 40% decreased hepatic ABCG8 mRNA expression (P=0.009). Effects at the ABO locus were related to SNP rs657152 (combined P=9.4×10−13). Alleles of ABCG8 and ABO associated with elevated phytosterol levels displayed significant associations with increased CAD risk (rs4245791 odds ratio, 1.10; 95% CI, 1.06 to 1.14; P=2.2×10−6; rs657152 odds ratio, 1.13; 95% CI, 1.07 to 1.19; P=9.4×10−6), whereas alleles at ABCG8 associated with reduced phytosterol levels were associated with reduced CAD risk (rs41360247 odds ratio, 0.84; 95% CI, 0.78 to 0.91; P=1.3×10−5). Conclusion—Common variants in ABCG8 and ABO are strongly associated with serum phytosterol levels and show concordant and previously unknown associations with CAD.


BJUI | 2012

GATA5 CpG island methylation in renal cell cancer: a potential biomarker for metastasis and disease progression.

Inga Peters; Hendrik Eggers; Faranaz Atschekzei; Jörg Hennenlotter; Sandra Waalkes; Wolfgang Tränkenschuh; Anika Großhennig; Axel S. Merseburger; Arnulf Stenzl; Markus A. Kuczyk; Jürgen Serth

Whats known on the subject? and What does the study add?


World Journal of Urology | 2010

Treatment with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma is associated with drug-induced hyperparathyroidism: a single center experience in 59 patients

Philipp Ivanyi; Thomas Winkler; Anika Großhennig; Christoph Reuter; Axel S. Merseburger; Arnold Ganser; Viktor Grünwald


Pneumologie | 2015

Sozialmedizinische Aspekte der Rehabilitation bei Sarkoidose Ergebnisse der ProKaSaRe-Studie (Prospektive multizentrische Katamnesestudie Sarkoidose in der pneumologischen Rehabilitation).

Heike Buhr-Schinner; R Braune; B Quadder; W Buchbender; Rolf Heitmann; Stefan Hummel; Ulrich Tönnesmann; J van der Meyden; K Schultz; Stefanie Ernst; Anika Großhennig; Tanja Schleef; Heidrun Lingner


Pneumologie | 2014

Dyspnoe, Lebensqualität, psychische Belastung und Fatigue 6 Monate nach pneumologischer Rehabilitation bei Sarkoidose – Halbjahresdaten der multizentrischen ProKaSaRe-Studie

Heidrun Lingner; Anika Großhennig; W Buchbender; Heike Buhr-Schinner; Rolf Heitmann; Stefan Hummel; Ulrich Tönnesmann; J van der Meyden; R Braune; B Quadder; K Schultz


Pneumologie | 2013

Effektivität pneumologischer Rehabilitation bei Sarkoidose – Erste Langzeitdaten der multizentrischen ProKaSaRe-Studie

K Schultz; R Braune; B Quadder; W Buchbender; Heike Buhr-Schinner; Rolf Heitmann; Stefan Hummel; Ulrich Tönnesmann; J van der Meyden; Stefanie Ernst; Anika Großhennig; Tanja Schleef; Heidrun Lingner


European Respiratory Journal | 2013

Pulmonary rehabilitation in patients with sarcoidosis - The German multicenter study (ProKaSaRe): Short- and long-term effects

K Schultz; R Braune; B Quadder; W Buchbender; Heike Buhr-Schinner; Rolf Heitmann; Stefan Hummel; Ulrich Tönnesmann; Jochen van der Meyden; Anika Großhennig; Stefanie Ernst; Tanja Schleef; Heidrun Lingner

Collaboration


Dive into the Anika Großhennig's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Karin Halina Greiser

German Cancer Research Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge